{"title":"Advanced Modeling Techniques","markdown":{"yaml":{"title":"Advanced Modeling Techniques","format":{"revealjs":{"theme":"slides.scss","incremental":true,"slide-number":true,"logo":"../vchem.png","html-math-method":"katex","transition":"fade","background-transition":"fade","highlight-style":"ayu-mirage","footer":"[Back to Website](../index.html)\n"}},"editor_options":{"chunk_output_type":"console"},"editor":{"markdown":{"wrap":90}}},"headingText":"Learning Objectives and Outline","containsRefs":false,"markdown":"\n\n\n## Learning Objectives\n\n-   Be able to understand the basic concepts and identify the strengths and limitations of\n    alternative modeling techniques, including:\n\n    ::: nonincremental\n    -   Microsimulation (Monte Carlo simulation)\n\n    -   Discrete event simulation\n\n    -   Infectious disease (dynamic) models\n    :::\n\n## Outline\n\n-   Microsimulation (Monte Carlo simulation)\n\n-   Discrete event simulation\n\n-   Infectious disease (dynamic) models\n\n-   Comparison of model types\n\n# Microsimulation\n\n## Microsimulation models\n\n-   Markov simulation\n\n    -   Focuses on the average: essentially assuming infinite cohort of individuals\n        transitions through the model simultaneously to obtain the expected values\n\n-   Microsimulation\n\n    -   Synonyms = stochastic microsimulation, individual-based model, 1st order Monte\n        Carlo simulation\n\n    -   Hypothetical individuals transition through the model, one at a time\n\n## Steps {.smaller}\n\n1.  Determine initial state, using the distribution of starting probabilities\n\n    -   e.g. probability of starting in sick/healthy\n\n2.  Simulate individual trajectory through health states, using **random numbers** to\n    determine actual transitions (yes/no) from transition probabilities\n\n3.  Record \\# of cycles in each state\n\n4.  Repeat steps 1-3 many times (N)\n\n## Steps {.smaller}\n\n5.  Calculate mean \\# of cycles from sample of N\n\n    -   Can weight states by utility, cost, discount factor (same as with Markov models)\n\n## Random numbers\n\n![](images/paste-ECA4B291.png){fig-align=\"center\" width=\"700\"}\n\n![](images/paste-65EE9EB8.png){fig-align=\"center\" width=\"700\" height=\"259\"}\n\n## Markov cohort vs Microsimulation\n\n\\[Shift to Powerpoint...\\]\n\n## Example\n\nContext: Economic evaluation of TB prevention among people living with HIV in Tanzania\n\n[![Zhu et al., The Lancet Global Health,\n2022](images/paste-693A3914.png)](https://www.sciencedirect.com/science/article/pii/S2214109X22003722)\n\n## Example\n\n-   TB accounts for \\>25% deaths among people living with HIV\n\n-   Isoniazid preventive therapy (IPT) can prevent TB among people receiving\n    antiretroviral therapy (ART)\n\n-   HIV programmes are now initiating patients on ART with higher average CD4 cell counts\n    and lower tuberculosis risks under test-and-treat guidelines\n\n-   We aimed to investigate how this change has affected the health impact and\n    cost-effectiveness of IPT\n\n## Example\n\n![Zhu et al, The Lancet Global Health, 2022](images/paste-893141CB.png)\n\n## Example\n\n::: {.callout-note .fragment appearance=\"simple\"}\nWhy choose a microsimulation model?\n:::\n\n-   Individual-level characteristics on age, sex, CD4 cell count\n\n-   Tracking individual trajectory is crucial for this question\n\n    -   CD4 cell counts change with HIV treatment\n\n    -   Event rates (mortality and TB progression rates) are dependent on CD4 cell counts\n\n-   A markov cohort model wouldn't be able to capture these complex mechanisms!\n\n# Discrete event simulation\n\n## Microsimulation vs DES {.smaller}\n\n::: fragment\n::: {style=\"color: blue\"}\nMiscrosimulation\n:::\n\n![](images/paste-ADA3A919.png){fig-align=\"center\" width=\"1689\"}\n:::\n\n::: fragment\n::: {style=\"color: blue\"}\nDiscrete event simulation\n:::\n\n![](images/paste-F1424244.png){fig-align=\"center\" width=\"1687\"}\n:::\n\n## DES {.smaller}\n\n::: {style=\"font-size: 0.95em\"}\n-   **Similar to microsimulation,** DES simulates one individual at a time $\\rightarrow$\n    Subject to stochasticity\n\n-   **Different from microsimulation** (where time is discretized), DES models time\n    continuously\n\n-   **Pros:**\n\n    -   Faster: Skips unnecessary cycles where no events happen\n\n    -   More natural to implement when data are presented as time-to-event distributions\n        (wait time, length of stay in hospital, onset-to-treatment time for acute\n        conditions)\n\n-   **Cons:**\n\n    -   Less intuitive: \"time to death is sampled from a Weibull distribution of shape =\n        2.72, scale = 58.5\" (DES) vs. \"the probability of death in year 1 is 0.038\"\n        (Microsim)\n\n    -   Those time steps may be useful even if there's no event! (In the HIV/TB example,\n        CD4 cell count is updated every cycle to recalculate TB and death risks)\n:::\n\n## Example\n\n![](images/paste-CFBFCE8E.png)\n\n## Example\n\n![Graves et al, 2017](images/paste-D21543AB.png)\n\n# Infectious disease (dynamic) models\n\n## Why dynamic models?\n\n-   So far all model types we discussed assume that individuals in the model cohort\n    experience events independently\n\n    -   Appropriate assumption for most chronic disease models\n\n-   But what about infectious diseases (e.g. COVID) where individuals interact with each\n    other?\n\n    -   E.g. the risk of acquiring COVID for a healthy (susceptible) individual depends on\n        how many individuals current have COVID in the population\n\n## The SIR model\n\nThe most classic model in infectious disease epidemiology. Appropriate for many common\ninfectious diseases (e.g., the flu).\n\n![](images/clipboard-1493296139.png)\n\n## The SIR model\n\n![Source: Vynnycky, Emilia; White, Richard. An Introduction to Infectious Disease\nModelling.](images/paste-36EB7CF0.png)\n\n## Variants of the SIR model {.smaller}\n\n-   From the simple SIR process, we can add more stuctures to reflect the process of a\n    particular disease, for example:\n\n    -   Age- or sex- mixing: appropriate for sexually transmitted diseases\n\n    -   A stage where individuals are infected but not infectious: appropriate for\n        diseases with a latent stage, e.g., TB, COVID-19\n\n![](images/SEIR.svg){.fragment fig-align=\"center\"}\n\n##  {.smaller}\n\nDynamic models are often expressed/solved as difference/differential equations\n\n::: columns\n::: {.column width=\"50%\"}\nExample:\n\n![](images/paste-A420C388.png){fig-align=\"center\" width=\"262\"}\n:::\n\n::: {.column width=\"50%\"}\nThey can be solved by hand or using softwares (e.g. deSolve package in R)\n:::\n:::\n\n# How to choose the right model?\n\n## Comparison of model types\n\n::: {style=\"font-size: 0.5em; line-height: 1\"}\n+---------------------+--------------------------------+--------------------------------+\n| Model Type          | Strengths                      | Limitations                    |\n+=====================+================================+================================+\n| Decision tree       | Transparent                    | Difficult to capture           |\n|                     |                                | progression over time or       |\n|                     | Straightforward calculations   | repeated events                |\n+---------------------+--------------------------------+--------------------------------+\n| Markov cohort       | Able to capture repeated       | Difficult to capture           |\n|                     | events over time               | individual heterogeneity or    |\n|                     |                                | track history of events        |\n|                     | Fast run speed                 |                                |\n|                     |                                | Hard to handle complicated     |\n|                     |                                | disease process (subject to    |\n|                     |                                | state explosion)               |\n+---------------------+--------------------------------+--------------------------------+\n:::\n\n## Comparison of model types\n\n::: {style=\"font-size: 0.5em; line-height: 1\"}\n+---------------------+--------------------------------+--------------------------------+\n| Model Type          | Strengths                      | Limitations                    |\n+=====================+================================+================================+\n| Decision tree       | Transparent                    | Difficult to capture           |\n|                     |                                | progression over time or       |\n|                     | Straightforward calculations   | repeated events                |\n+---------------------+--------------------------------+--------------------------------+\n| Markov cohort       | Able to capture repeated       | Difficult to capture           |\n|                     | events over time               | individual heterogeneity or    |\n|                     |                                | track history of events        |\n|                     | Fast run speed                 |                                |\n|                     |                                | Hard to handle complicated     |\n|                     |                                | disease process (subject to    |\n|                     |                                | state explosion)               |\n+---------------------+--------------------------------+--------------------------------+\n| **Microsimulation** | **Easy to track history**      | **Requires a large number of   |\n|                     |                                | runs to converge**             |\n|                     | **Very powerful and flexible** |                                |\n|                     |                                | **Slowest run speed**          |\n+---------------------+--------------------------------+--------------------------------+\n:::\n\n## Comparison of model types\n\n::: {style=\"font-size: 0.58em; line-height: 1\"}\n+-------------------------------+-------------------------------------------+--------------------------------------------------------------------------------------------------------+\n| Model Type                    | Strengths                                 | Limitations                                                                                            |\n+===============================+===========================================+========================================================================================================+\n| Decision tree                 | Transparent                               | Difficult to capture progression over time or repeated events                                          |\n|                               |                                           |                                                                                                        |\n|                               | Straightforward calculations              |                                                                                                        |\n+-------------------------------+-------------------------------------------+--------------------------------------------------------------------------------------------------------+\n| Markov cohort                 | Able to capture repeated events over time | Difficult to capture individual heterogeneity or track history of events                               |\n|                               |                                           |                                                                                                        |\n|                               | Fast run speed                            | Hard to handle complicated disease process (subject to state explosion)                                |\n+-------------------------------+-------------------------------------------+--------------------------------------------------------------------------------------------------------+\n| Microsimulation               | Easy to track history                     | Requires a large number of runs to converge                                                            |\n|                               |                                           |                                                                                                        |\n|                               | Very powerful and flexible                | Slowest run speed                                                                                      |\n+-------------------------------+-------------------------------------------+--------------------------------------------------------------------------------------------------------+\n| **Discrete event simulation** | **Easy to track history**                 | **Requires a large number of runs to converge**                                                        |\n|                               |                                           |                                                                                                        |\n|                               | **Faster than microsimulation**           | **Time-to-event distributions are less intuitive and harder to obtain than event rates/probabilities** |\n+-------------------------------+-------------------------------------------+--------------------------------------------------------------------------------------------------------+\n:::\n\n## Comparison of model types\n\n::: {style=\"font-size: 0.50em; line-height: 1\"}\n+---------------------------+---------------------------------------------+----------------------------------------------------------------------------------------------------+\n| Model Type                | Strengths                                   | Limitations                                                                                        |\n+===========================+=============================================+====================================================================================================+\n| Decision tree             | Transparent                                 | Difficult to capture progression over time or repeated events                                      |\n|                           |                                             |                                                                                                    |\n|                           | Straightforward calculations                |                                                                                                    |\n+---------------------------+---------------------------------------------+----------------------------------------------------------------------------------------------------+\n| Markov cohort             | Able to capture repeated events over time   | Difficult to capture individual heterogeneity or track history of events                           |\n|                           |                                             |                                                                                                    |\n|                           | Fast run speed                              | Hard to handle complicated disease process (subject to state explosion)                            |\n+---------------------------+---------------------------------------------+----------------------------------------------------------------------------------------------------+\n| Microsimulation           | Easy to track history                       | Requires a large number of runs to converge                                                        |\n|                           |                                             |                                                                                                    |\n|                           | Very powerful and flexible                  | Slowest run speed                                                                                  |\n+---------------------------+---------------------------------------------+----------------------------------------------------------------------------------------------------+\n| Discrete event simulation | Easy to track history                       | Requires a large number of runs to converge                                                        |\n|                           |                                             |                                                                                                    |\n|                           | Faster than microsimulation                 | Time-to-event distributions are less intuitive and harder to obtain than event rates/probabilities |\n+---------------------------+---------------------------------------------+----------------------------------------------------------------------------------------------------+\n| **Dynamic**               | **Able to capture transmission of disease** | **More data requirements (e.g. contact patterns in populaton)**                                    |\n|                           |                                             |                                                                                                    |\n|                           |                                             | **More black-box**                                                                                 |\n+---------------------------+---------------------------------------------+----------------------------------------------------------------------------------------------------+\n:::\n\n\n## How to choose the right model?\n\nFactors to consider:\n\n-   Policy question/interventions\n\n-   Data availability\n\n-   Natural history of disease\n\n-   Computational resources available\n","srcMarkdownNoYaml":"\n\n# Learning Objectives and Outline\n\n## Learning Objectives\n\n-   Be able to understand the basic concepts and identify the strengths and limitations of\n    alternative modeling techniques, including:\n\n    ::: nonincremental\n    -   Microsimulation (Monte Carlo simulation)\n\n    -   Discrete event simulation\n\n    -   Infectious disease (dynamic) models\n    :::\n\n## Outline\n\n-   Microsimulation (Monte Carlo simulation)\n\n-   Discrete event simulation\n\n-   Infectious disease (dynamic) models\n\n-   Comparison of model types\n\n# Microsimulation\n\n## Microsimulation models\n\n-   Markov simulation\n\n    -   Focuses on the average: essentially assuming infinite cohort of individuals\n        transitions through the model simultaneously to obtain the expected values\n\n-   Microsimulation\n\n    -   Synonyms = stochastic microsimulation, individual-based model, 1st order Monte\n        Carlo simulation\n\n    -   Hypothetical individuals transition through the model, one at a time\n\n## Steps {.smaller}\n\n1.  Determine initial state, using the distribution of starting probabilities\n\n    -   e.g. probability of starting in sick/healthy\n\n2.  Simulate individual trajectory through health states, using **random numbers** to\n    determine actual transitions (yes/no) from transition probabilities\n\n3.  Record \\# of cycles in each state\n\n4.  Repeat steps 1-3 many times (N)\n\n## Steps {.smaller}\n\n5.  Calculate mean \\# of cycles from sample of N\n\n    -   Can weight states by utility, cost, discount factor (same as with Markov models)\n\n## Random numbers\n\n![](images/paste-ECA4B291.png){fig-align=\"center\" width=\"700\"}\n\n![](images/paste-65EE9EB8.png){fig-align=\"center\" width=\"700\" height=\"259\"}\n\n## Markov cohort vs Microsimulation\n\n\\[Shift to Powerpoint...\\]\n\n## Example\n\nContext: Economic evaluation of TB prevention among people living with HIV in Tanzania\n\n[![Zhu et al., The Lancet Global Health,\n2022](images/paste-693A3914.png)](https://www.sciencedirect.com/science/article/pii/S2214109X22003722)\n\n## Example\n\n-   TB accounts for \\>25% deaths among people living with HIV\n\n-   Isoniazid preventive therapy (IPT) can prevent TB among people receiving\n    antiretroviral therapy (ART)\n\n-   HIV programmes are now initiating patients on ART with higher average CD4 cell counts\n    and lower tuberculosis risks under test-and-treat guidelines\n\n-   We aimed to investigate how this change has affected the health impact and\n    cost-effectiveness of IPT\n\n## Example\n\n![Zhu et al, The Lancet Global Health, 2022](images/paste-893141CB.png)\n\n## Example\n\n::: {.callout-note .fragment appearance=\"simple\"}\nWhy choose a microsimulation model?\n:::\n\n-   Individual-level characteristics on age, sex, CD4 cell count\n\n-   Tracking individual trajectory is crucial for this question\n\n    -   CD4 cell counts change with HIV treatment\n\n    -   Event rates (mortality and TB progression rates) are dependent on CD4 cell counts\n\n-   A markov cohort model wouldn't be able to capture these complex mechanisms!\n\n# Discrete event simulation\n\n## Microsimulation vs DES {.smaller}\n\n::: fragment\n::: {style=\"color: blue\"}\nMiscrosimulation\n:::\n\n![](images/paste-ADA3A919.png){fig-align=\"center\" width=\"1689\"}\n:::\n\n::: fragment\n::: {style=\"color: blue\"}\nDiscrete event simulation\n:::\n\n![](images/paste-F1424244.png){fig-align=\"center\" width=\"1687\"}\n:::\n\n## DES {.smaller}\n\n::: {style=\"font-size: 0.95em\"}\n-   **Similar to microsimulation,** DES simulates one individual at a time $\\rightarrow$\n    Subject to stochasticity\n\n-   **Different from microsimulation** (where time is discretized), DES models time\n    continuously\n\n-   **Pros:**\n\n    -   Faster: Skips unnecessary cycles where no events happen\n\n    -   More natural to implement when data are presented as time-to-event distributions\n        (wait time, length of stay in hospital, onset-to-treatment time for acute\n        conditions)\n\n-   **Cons:**\n\n    -   Less intuitive: \"time to death is sampled from a Weibull distribution of shape =\n        2.72, scale = 58.5\" (DES) vs. \"the probability of death in year 1 is 0.038\"\n        (Microsim)\n\n    -   Those time steps may be useful even if there's no event! (In the HIV/TB example,\n        CD4 cell count is updated every cycle to recalculate TB and death risks)\n:::\n\n## Example\n\n![](images/paste-CFBFCE8E.png)\n\n## Example\n\n![Graves et al, 2017](images/paste-D21543AB.png)\n\n# Infectious disease (dynamic) models\n\n## Why dynamic models?\n\n-   So far all model types we discussed assume that individuals in the model cohort\n    experience events independently\n\n    -   Appropriate assumption for most chronic disease models\n\n-   But what about infectious diseases (e.g. COVID) where individuals interact with each\n    other?\n\n    -   E.g. the risk of acquiring COVID for a healthy (susceptible) individual depends on\n        how many individuals current have COVID in the population\n\n## The SIR model\n\nThe most classic model in infectious disease epidemiology. Appropriate for many common\ninfectious diseases (e.g., the flu).\n\n![](images/clipboard-1493296139.png)\n\n## The SIR model\n\n![Source: Vynnycky, Emilia; White, Richard. An Introduction to Infectious Disease\nModelling.](images/paste-36EB7CF0.png)\n\n## Variants of the SIR model {.smaller}\n\n-   From the simple SIR process, we can add more stuctures to reflect the process of a\n    particular disease, for example:\n\n    -   Age- or sex- mixing: appropriate for sexually transmitted diseases\n\n    -   A stage where individuals are infected but not infectious: appropriate for\n        diseases with a latent stage, e.g., TB, COVID-19\n\n![](images/SEIR.svg){.fragment fig-align=\"center\"}\n\n##  {.smaller}\n\nDynamic models are often expressed/solved as difference/differential equations\n\n::: columns\n::: {.column width=\"50%\"}\nExample:\n\n![](images/paste-A420C388.png){fig-align=\"center\" width=\"262\"}\n:::\n\n::: {.column width=\"50%\"}\nThey can be solved by hand or using softwares (e.g. deSolve package in R)\n:::\n:::\n\n# How to choose the right model?\n\n## Comparison of model types\n\n::: {style=\"font-size: 0.5em; line-height: 1\"}\n+---------------------+--------------------------------+--------------------------------+\n| Model Type          | Strengths                      | Limitations                    |\n+=====================+================================+================================+\n| Decision tree       | Transparent                    | Difficult to capture           |\n|                     |                                | progression over time or       |\n|                     | Straightforward calculations   | repeated events                |\n+---------------------+--------------------------------+--------------------------------+\n| Markov cohort       | Able to capture repeated       | Difficult to capture           |\n|                     | events over time               | individual heterogeneity or    |\n|                     |                                | track history of events        |\n|                     | Fast run speed                 |                                |\n|                     |                                | Hard to handle complicated     |\n|                     |                                | disease process (subject to    |\n|                     |                                | state explosion)               |\n+---------------------+--------------------------------+--------------------------------+\n:::\n\n## Comparison of model types\n\n::: {style=\"font-size: 0.5em; line-height: 1\"}\n+---------------------+--------------------------------+--------------------------------+\n| Model Type          | Strengths                      | Limitations                    |\n+=====================+================================+================================+\n| Decision tree       | Transparent                    | Difficult to capture           |\n|                     |                                | progression over time or       |\n|                     | Straightforward calculations   | repeated events                |\n+---------------------+--------------------------------+--------------------------------+\n| Markov cohort       | Able to capture repeated       | Difficult to capture           |\n|                     | events over time               | individual heterogeneity or    |\n|                     |                                | track history of events        |\n|                     | Fast run speed                 |                                |\n|                     |                                | Hard to handle complicated     |\n|                     |                                | disease process (subject to    |\n|                     |                                | state explosion)               |\n+---------------------+--------------------------------+--------------------------------+\n| **Microsimulation** | **Easy to track history**      | **Requires a large number of   |\n|                     |                                | runs to converge**             |\n|                     | **Very powerful and flexible** |                                |\n|                     |                                | **Slowest run speed**          |\n+---------------------+--------------------------------+--------------------------------+\n:::\n\n## Comparison of model types\n\n::: {style=\"font-size: 0.58em; line-height: 1\"}\n+-------------------------------+-------------------------------------------+--------------------------------------------------------------------------------------------------------+\n| Model Type                    | Strengths                                 | Limitations                                                                                            |\n+===============================+===========================================+========================================================================================================+\n| Decision tree                 | Transparent                               | Difficult to capture progression over time or repeated events                                          |\n|                               |                                           |                                                                                                        |\n|                               | Straightforward calculations              |                                                                                                        |\n+-------------------------------+-------------------------------------------+--------------------------------------------------------------------------------------------------------+\n| Markov cohort                 | Able to capture repeated events over time | Difficult to capture individual heterogeneity or track history of events                               |\n|                               |                                           |                                                                                                        |\n|                               | Fast run speed                            | Hard to handle complicated disease process (subject to state explosion)                                |\n+-------------------------------+-------------------------------------------+--------------------------------------------------------------------------------------------------------+\n| Microsimulation               | Easy to track history                     | Requires a large number of runs to converge                                                            |\n|                               |                                           |                                                                                                        |\n|                               | Very powerful and flexible                | Slowest run speed                                                                                      |\n+-------------------------------+-------------------------------------------+--------------------------------------------------------------------------------------------------------+\n| **Discrete event simulation** | **Easy to track history**                 | **Requires a large number of runs to converge**                                                        |\n|                               |                                           |                                                                                                        |\n|                               | **Faster than microsimulation**           | **Time-to-event distributions are less intuitive and harder to obtain than event rates/probabilities** |\n+-------------------------------+-------------------------------------------+--------------------------------------------------------------------------------------------------------+\n:::\n\n## Comparison of model types\n\n::: {style=\"font-size: 0.50em; line-height: 1\"}\n+---------------------------+---------------------------------------------+----------------------------------------------------------------------------------------------------+\n| Model Type                | Strengths                                   | Limitations                                                                                        |\n+===========================+=============================================+====================================================================================================+\n| Decision tree             | Transparent                                 | Difficult to capture progression over time or repeated events                                      |\n|                           |                                             |                                                                                                    |\n|                           | Straightforward calculations                |                                                                                                    |\n+---------------------------+---------------------------------------------+----------------------------------------------------------------------------------------------------+\n| Markov cohort             | Able to capture repeated events over time   | Difficult to capture individual heterogeneity or track history of events                           |\n|                           |                                             |                                                                                                    |\n|                           | Fast run speed                              | Hard to handle complicated disease process (subject to state explosion)                            |\n+---------------------------+---------------------------------------------+----------------------------------------------------------------------------------------------------+\n| Microsimulation           | Easy to track history                       | Requires a large number of runs to converge                                                        |\n|                           |                                             |                                                                                                    |\n|                           | Very powerful and flexible                  | Slowest run speed                                                                                  |\n+---------------------------+---------------------------------------------+----------------------------------------------------------------------------------------------------+\n| Discrete event simulation | Easy to track history                       | Requires a large number of runs to converge                                                        |\n|                           |                                             |                                                                                                    |\n|                           | Faster than microsimulation                 | Time-to-event distributions are less intuitive and harder to obtain than event rates/probabilities |\n+---------------------------+---------------------------------------------+----------------------------------------------------------------------------------------------------+\n| **Dynamic**               | **Able to capture transmission of disease** | **More data requirements (e.g. contact patterns in populaton)**                                    |\n|                           |                                             |                                                                                                    |\n|                           |                                             | **More black-box**                                                                                 |\n+---------------------------+---------------------------------------------+----------------------------------------------------------------------------------------------------+\n:::\n\n\n## How to choose the right model?\n\nFactors to consider:\n\n-   Policy question/interventions\n\n-   Data availability\n\n-   Natural history of disease\n\n-   Computational resources available\n"},"formats":{"revealjs":{"identifier":{"display-name":"RevealJS","target-format":"revealjs","base-format":"revealjs"},"execute":{"fig-width":10,"fig-height":5,"fig-format":"retina","fig-dpi":96,"df-print":"default","error":false,"eval":true,"cache":null,"freeze":true,"echo":false,"output":true,"warning":false,"include":true,"keep-md":false,"keep-ipynb":false,"ipynb":null,"enabled":null,"daemon":null,"daemon-restart":false,"debug":false,"ipynb-filters":[],"ipynb-shell-interactivity":null,"plotly-connected":true,"engine":"markdown"},"render":{"keep-tex":false,"keep-typ":false,"keep-source":false,"keep-hidden":false,"prefer-html":false,"output-divs":true,"output-ext":"html","fig-align":"default","fig-pos":null,"fig-env":null,"code-fold":"none","code-overflow":"scroll","code-link":false,"code-line-numbers":true,"code-tools":false,"tbl-colwidths":"auto","merge-includes":true,"inline-includes":false,"preserve-yaml":false,"latex-auto-mk":true,"latex-auto-install":true,"latex-clean":true,"latex-min-runs":1,"latex-max-runs":10,"latex-makeindex":"makeindex","latex-makeindex-opts":[],"latex-tlmgr-opts":[],"latex-input-paths":[],"latex-output-dir":null,"link-external-icon":false,"link-external-newwindow":false,"self-contained-math":false,"format-resources":[]},"pandoc":{"standalone":true,"wrap":"none","default-image-extension":"png","html-math-method":"katex","slide-level":2,"to":"revealjs","incremental":true,"highlight-style":"ayu-mirage","output-file":"lec_advanced-modeling-techniques.html"},"language":{"toc-title-document":"Table of contents","toc-title-website":"On this page","related-formats-title":"Other Formats","related-notebooks-title":"Notebooks","source-notebooks-prefix":"Source","other-links-title":"Other Links","code-links-title":"Code Links","launch-dev-container-title":"Launch Dev Container","launch-binder-title":"Launch Binder","article-notebook-label":"Article Notebook","notebook-preview-download":"Download Notebook","notebook-preview-download-src":"Download Source","notebook-preview-back":"Back to Article","manuscript-meca-bundle":"MECA Bundle","section-title-abstract":"Abstract","section-title-appendices":"Appendices","section-title-footnotes":"Footnotes","section-title-references":"References","section-title-reuse":"Reuse","section-title-copyright":"Copyright","section-title-citation":"Citation","appendix-attribution-cite-as":"For attribution, please cite this work as:","appendix-attribution-bibtex":"BibTeX citation:","appendix-view-license":"View License","title-block-author-single":"Author","title-block-author-plural":"Authors","title-block-affiliation-single":"Affiliation","title-block-affiliation-plural":"Affiliations","title-block-published":"Published","title-block-modified":"Modified","title-block-keywords":"Keywords","callout-tip-title":"Tip","callout-note-title":"Note","callout-warning-title":"Warning","callout-important-title":"Important","callout-caution-title":"Caution","code-summary":"Code","code-tools-menu-caption":"Code","code-tools-show-all-code":"Show All Code","code-tools-hide-all-code":"Hide All Code","code-tools-view-source":"View Source","code-tools-source-code":"Source Code","tools-share":"Share","tools-download":"Download","code-line":"Line","code-lines":"Lines","copy-button-tooltip":"Copy to Clipboard","copy-button-tooltip-success":"Copied!","repo-action-links-edit":"Edit this page","repo-action-links-source":"View source","repo-action-links-issue":"Report an issue","back-to-top":"Back to top","search-no-results-text":"No results","search-matching-documents-text":"matching documents","search-copy-link-title":"Copy link to search","search-hide-matches-text":"Hide additional matches","search-more-match-text":"more match in this document","search-more-matches-text":"more matches in this document","search-clear-button-title":"Clear","search-text-placeholder":"","search-detached-cancel-button-title":"Cancel","search-submit-button-title":"Submit","search-label":"Search","toggle-section":"Toggle section","toggle-sidebar":"Toggle sidebar navigation","toggle-dark-mode":"Toggle dark mode","toggle-reader-mode":"Toggle reader mode","toggle-navigation":"Toggle navigation","crossref-fig-title":"Figure","crossref-tbl-title":"Table","crossref-lst-title":"Listing","crossref-thm-title":"Theorem","crossref-lem-title":"Lemma","crossref-cor-title":"Corollary","crossref-prp-title":"Proposition","crossref-cnj-title":"Conjecture","crossref-def-title":"Definition","crossref-exm-title":"Example","crossref-exr-title":"Exercise","crossref-ch-prefix":"Chapter","crossref-apx-prefix":"Appendix","crossref-sec-prefix":"Section","crossref-eq-prefix":"Equation","crossref-lof-title":"List of Figures","crossref-lot-title":"List of Tables","crossref-lol-title":"List of Listings","environment-proof-title":"Proof","environment-remark-title":"Remark","environment-solution-title":"Solution","listing-page-order-by":"Order By","listing-page-order-by-default":"Default","listing-page-order-by-date-asc":"Oldest","listing-page-order-by-date-desc":"Newest","listing-page-order-by-number-desc":"High to Low","listing-page-order-by-number-asc":"Low to High","listing-page-field-date":"Date","listing-page-field-title":"Title","listing-page-field-description":"Description","listing-page-field-author":"Author","listing-page-field-filename":"File Name","listing-page-field-filemodified":"Modified","listing-page-field-subtitle":"Subtitle","listing-page-field-readingtime":"Reading Time","listing-page-field-wordcount":"Word Count","listing-page-field-categories":"Categories","listing-page-minutes-compact":"{0} min","listing-page-category-all":"All","listing-page-no-matches":"No matching items","listing-page-words":"{0} words","listing-page-filter":"Filter","draft":"Draft"},"metadata":{"lang":"en","fig-responsive":false,"quarto-version":"1.8.24","auto-stretch":true,"title":"Advanced Modeling Techniques","editor_options":{"chunk_output_type":"console"},"editor":{"markdown":{"wrap":90}},"theme":"slides.scss","slideNumber":true,"logo":"../vchem.png","transition":"fade","backgroundTransition":"fade","footer":"[Back to Website](../index.html)\n"}}},"projectFormats":["html"]}